Joseph Kennedy III actually said...

So you say that you need to fund continued scientific innovation.

Amgen establishes a list price for our medicines in the context of an established set of pricing principles.

Is it really appropriate to continue to keep charging the taxpayer for those research risks on the back of an old product?

So that means the dollars actually going to cleanup are a fraction of what is appropriate.